You just read:

UCLA Team Reports Positive Topline Results from Double-Blind Trial of NeuroSigma's Non-Invasive eTNS System for Treatment of Pediatric ADHD

News provided by

NeuroSigma

30 Oct, 2017, 11:00 GMT